EuBiologics Co., Ltd. (KOSDAQ:206650)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Biological Products and Medical Supplies	96.04B
Biological Products and Medical Supplies Growth	38.45%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Africa	70.08B
Africa Growth	24.21%
Asia	10.96B
Asia Growth	4601.88%
Middle East	8.57B
Middle East Growth	44.40%
Europe	5.55B
South Korea	865.79M
South Korea Growth	-65.46%
Other	13.29M
Other Growth	-99.25%